Phoenix Molecular Designs team members meet with investors to discuss partnership opportunities at premier Life Science events in the US.

January 9, 2018 - Dr. Sandra Dunn joined 500+ companies at the annual Redefining Early Stage Investments (RESI) conference in San Francisco, one of the most important investor events in the Biotech calendar. She was also invited to attend the WuXi Global Forum, to hear from the industry thought leaders about their thoughts on the rapidly changing landscape of the Biotech industry.

March 1, 2018 - Our CSO Dr. Gerrit Los attended the 2018 premier partnering event of the year, the 8th annual BIOCOM Global Life Science Partnering Conference in La Jolla, California. This conference was an exclusive forum to showcase our work to wide range of investors.